Launch of semi-synthetic artemisinin a milestone for malaria, synthetic biology
Twelve years after a breakthrough discovery in his University of California, Berkeley, laboratory, professor of chemical engineering Jay Keasling is seeing his dream come true.
Medications
Apr 11, 2013 |
not rated yet |
0
New strategy helps young lymphoma patients avoid radiation treatment
(HealthDay)—A new treatment approach may mean that young people with a form of lymphoma can go without radiation therapy, sparing them side effects or raised cancer risks down the road.
Cancer
Apr 10, 2013 |
5 / 5 (1) |
0
U-M researchers find new way to clear cholesterol from the blood
Researchers at the University of Michigan have identified a new potential therapeutic target for lowering cholesterol that could be an alternative or complementary therapy to statins.
Cardiology
Apr 10, 2013 |
5 / 5 (1) |
0
|
Naturally occurring substance proves effective against deadly skin cancer in laboratory tests
For the first time, scientists have demonstrated the mechanism of action of gossypin, a naturally-occurring substance found in fruits and vegetables, as a treatment for melanoma, which causes the majority of deaths from skin ...
Cancer
Apr 10, 2013 |
5 / 5 (1) |
0
Cardiopoietic 'smart' stem cells show promise in heart failure patients
Translating a Mayo Clinic stem-cell discovery, an international team has demonstrated that therapy with cardiopoietic (cardiogenically-instructed) or "smart" stem cells can improve heart health for people suffering from heart ...
Cardiology
Apr 10, 2013 |
5 / 5 (1) |
2
Team makes breakthrough in search for neurodegenerative disease treatments
A significant breakthrough has been made by scientists at The University of Manchester towards developing an effective treatment for neurodegenerative diseases such as Huntington's, Alzheimer's and Parkinson's.
Medical research
Apr 10, 2013 |
4.3 / 5 (3) |
0
|
Engineered small pox may kill liver cancer
As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma (HCC) or liver cancer. Pexa-Vec ...
Cancer
Apr 10, 2013 |
5 / 5 (2) |
0
Engineered antibody demonstrated safety, efficacy in wide range of advanced tumors
(Medical Xpress)—The engineered antibody MPDL3280A, which targets a protein called programmed death-ligand 1 (PD-L1), was safe and effective for several cancers, according to phase I study results presented at the AACR ...
Cancer
Apr 10, 2013 |
4 / 5 (1) |
0
Treatment leads to near-normal life expectancy for people with HIV in South Africa
In South Africa, people with HIV who start treatment with anti-AIDS drugs (antiretroviral therapy) have life expectancies around 80% of that of the general population provided that they start treatment before their CD4 count ...
HIV & AIDS
Apr 09, 2013 |
2 / 5 (1) |
0
Indo-Canadian student gives boost to cancer treatment (Update)
A Canadian high school student has improved an ineffective experimental cancer therapy with a simple tweak—pairing it with antibiotics—earning accolades Tuesday from a panel of eminent scientists.
Cancer
Apr 09, 2013 |
5 / 5 (2) |
0
Few to no work efficiencies when different providers read different scans on same patient
According to a new study published online in the Journal of the American College of Radiology, any efficiencies in physician interpretation and diagnosis gained when different providers interpret different medical imagin ...
Other
Apr 09, 2013 |
not rated yet |
0
25 percent don't complete recommended breast cancer treatment
One-quarter of women who should take hormone-blocking therapies as part of their breast cancer treatment either do not start or do not complete the five-year course, according to a new study led by University of Michigan ...
Cancer
Apr 09, 2013 |
not rated yet |
0
One-two punch could be key in treating blindness
Researchers have discovered that using two kinds of therapy in tandem may be a knockout combo against inherited disorders that cause blindness. While their study focused on man's best friend, the treatment ...
Ophthalmology
Apr 09, 2013 |
5 / 5 (3) |
0
|
Patients with BRCA1 mutations, but not BRCA2 mutations, had poorer prognosis compared with noncarriers
Patients with breast cancer who had a BRCA1 mutation had significantly worse overall and recurrence-free survival rates compared with patients without BRCA mutations, but no evidence for a difference in survival was found ...
Cancer
Apr 09, 2013 |
5 / 5 (1) |
0
New brain cancer treatment may be more effective, less toxic
(Medical Xpress)—A Phase 2 clinical trial testing a new protocol for treating a relatively rare form of brain cancer, primary CNS lymphoma, may change the standard of care for this disease, according to ...
Cancer
Apr 09, 2013 |
not rated yet |
0
|
